These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12579121)

  • 1. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.
    Grayling M; Deakin CD
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):426-7. PubMed ID: 12579121
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
    Taylor K; Holtby H
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):566. PubMed ID: 16077431
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylene blue for refractory hypotension: a case report.
    Weissgerber AJ
    AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
    Yiu P; Robin J; Pattison CW
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):195-6. PubMed ID: 10384205
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue.
    Evora PR; Simon MR
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):306-13. PubMed ID: 17941276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
    Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
    Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegic syndrome--the role of methylene blue.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.
    Sparicio D; Landoni G; Pappalardo F; Crivellari M; Cerchierini E; Marino G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):592-3. PubMed ID: 14762380
    [No Abstract]   [Full Text] [Related]  

  • 10. [Echocardiographic study of bacterial endocarditis localized on the aortic valve. Apropos of 20 cases].
    Sabot G; Birmacker A; Pinaud-Dahan M; Fauvel JM; Bernadet P; Bounhoure JP
    Arch Mal Coeur Vaiss; 1980 Aug; 73(8):961-9. PubMed ID: 6774685
    [No Abstract]   [Full Text] [Related]  

  • 11. Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
    Evora PR
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):632-4. PubMed ID: 10694631
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass.
    Pagni S; Austin EH
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1297-8. PubMed ID: 10838557
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful aortic valve replacement for infective endocarditis in a patient with severe liver cirrhosis.
    Takahashi M; Li TS; Ikeda Y; Ito H; Mikamo A; Hamano K
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):287-9. PubMed ID: 16977302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.
    Faber P; Ronald A; Millar BW
    Anaesthesia; 2005 Jun; 60(6):575-87. PubMed ID: 15918829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.
    Evora PR; Levin RL
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):895-6; author reply 896. PubMed ID: 15001923
    [No Abstract]   [Full Text] [Related]  

  • 16. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass.
    Overand PT; Teply JF
    Anesth Analg; 1998 Jun; 86(6):1207-9. PubMed ID: 9620504
    [No Abstract]   [Full Text] [Related]  

  • 18. Disastrous course of recurrent infective endocarditis after tooth extraction in a young patient with bicuspid aortic valve.
    Zartner P; Gamillscheg A; Rigler B; Beitzke A
    Klin Padiatr; 2007; 219(1):44-6. PubMed ID: 16586273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin.
    Del Duca D; Sheth SS; Clarke AE; Lachapelle KJ; Ergina PL
    Ann Thorac Surg; 2009 Feb; 87(2):640-2. PubMed ID: 19161806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.